Previous 10 | Next 10 |
In January 2020, only 0.24% of total medical claims in the U.S. were telemedicine-related. One year later, they totaled 7%. It took 15 years for e-commerce penetration to rise from less than 1% to over 7%. The pandemic helped telemedicine do it in one. Population-wide immunity to ...
If you were investing heavily in tech/growth stocks over the past 11 years, we wish to congratulate you. We're not here to say that the next 11 years won't be the same, rather to suggest that you should treat your portfolio the same way you treat your body. If you've vaccinated yo...
Rep. Frank Pallone, Jr. (D-N.J.) reintroduced H.R. 3, legislation that would allow the federal government to negotiate prescription drug prices.The bill would cap seniors' out-of-pocket costs on prescription drugs to $2000/year, require drugmakers to issue rebates to the federal government if...
This has been a long, long boom in the amount of money that's flowed into this sector, and I don't think I've ever seen anything like it in my own career. This has been VC money going into early-stage startups, it's been IPOs, it's been follow-on financing of already public companies....
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of thi...
Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12, 36% of the entire US population has received at least one vaccine, and 79% of those ...
The performance of most pharmaceutical stocks has been underwhelming over the past year. The benchmark iShares US Pharmaceuticals ETF (NYSEMKT: IHE) has underperformed the S&P 500 by almost 20% in this time, and some companies in particular look especially cheap. Their s...
In our opinion, telehealth will remain the leading segment of the internet healthcare market as the market shifts away from in-person medical visits. According to Apple CEO Tim Cook, “I believe, if you zoom out into the future, and you look back, and you ask the question, ...
iShares U.S. Pharmaceuticals ETF (IHE) - $0.6348.30-Day SEC Yield of 1.34% as of Feb. 26.Payable Mar 31; for shareholders of record Mar 26; ex-div Mar 25. For further details see: iShares U.S. Pharmaceuticals ETF declares quarterly distribution of $0.6348
Drugmakers are set to save the world from COVID-19 but their shares have lagged the broader market in the past year, making the group look like one of the best pockets of value in a richly priced stock market, Barron's reports.Drug stocks have not been so inexpensive relative to the S&P 5...
News, Short Squeeze, Breakout and More Instantly...
iShares U.S. Pharmaceutical Company Name:
IHE Stock Symbol:
NYSE Market:
2024-07-12 08:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-22 11:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-31 20:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...